Participate in Surveys and WIN POINTS!

Survey on Hereditary Angioedema (HAE)

According to a recent survey, hereditary angioedema is a rare genetic disorder that affects approximately 1 in 50,000 people worldwide. It is characterized by recurrent episodes of swelling in the skin and mucous membranes, which can be painful and potentially life-threatening if they occur in the airways or digestive tract. The condition results from a deficiency or dysfunction of C1 inhibitor protein, which regulates immune system activity and prevents excess fluid from leaking out of blood vessels into surrounding tissues. Symptoms may first appear during childhood or adolescence and often worsen over time without proper treatment. There are currently several medications available to prevent attacks or treat acute symptoms, including plasma-derived C1 inhibitor replacement therapy, bradykinin receptor antagonists, and kallikrein inhibitors. However, many patients still struggle to obtain prompt diagnosis and access to these treatments due to limited awareness among healthcare providers and high costs associated with their use. Ongoing research efforts are focused on improving diagnostic accuracy, developing new therapies with longer duration of action or better tolerability profiles than existing options, and exploring potential links between hereditary angioedema and other inflammatory conditions such as autoimmune disease or cancer.


To take this Survey and to participate in more such Surveys

Recommended Surveys

Survey on fungal infection


Survey on Parkinson's disease


Survey on thromboprophylaxis


Survey on hepatitis of unknown etiology in children


Survey on VTE


Survey on Childhood trauma


Survey on Invasive Meningococcal Disease


Survey on use of Cefoperazone


Hypothyroidism survey


Survey on Telemedicine Usage Among Healthcare Professionals


Survey on Heat Stroke


Survey on the importance of prenatal vitamins


Survey on uremia


CI-AKI awareness survey


Metoprolol Survey


Survey on use of Valproic acid


Soil infections


Survey on Lung cancer


Survey on Viral Hepatitis


Survey on childhood asthma



Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

2.

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

3.

Asymptomatic Brain Metastases in EGFR-Mutant NSCLC

4.

Mapping lifelong chronic health risks for childhood cancer survivors

5.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

Whats more on Hidoc Dr.

News
Quizzes
Surveys
Events

Daily news to keep you up to date

Participate and win exciting prizes

Participate and win cash vouchers

Get updates on the latest events happening around the world



© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot